SNAPSHOT-AF: Who Gets Stroke Prevention for Atrial Fibrillation in the ED? Use of Oral Anticoagulation in the Emergency Department Setting in Australia & New Zealand

  • Reid, Christopher (Primary Chief Investigator (PCI))
  • Eccleston, David (Chief Investigator (CI))
  • Cullen, Louise (Chief Investigator (CI))

Project: Research

Project Details

Project Description

Current guidelines recommend oral anticoagulant therapy (OAC), with emphasis on novel agents, for stroke prevention in Atrial Fibrillation (AF). OAC reduce the risk of stroke from AF by 66%. However,recent US data suggests less than 50% of Non-Valvular AF patients receive appropriate OAC. There is little information regarding anticoagulant management of AF in Australia, with one small study reporting 40% of inpatients with AF are not anticoagulated, and no data in the emergency
Department setting. The aim of this study is to determine contemporary antithrombotic management of patients with AF presenting to emergency departments in Australia and New Zealand.
Short titleSNAPSHOT - AF
Effective start/end date1/01/1731/12/17